Sanofi (SNY) EBITDA Margin (2009 - 2026)
Sanofi (SNY) posted EBITDA Margin of 30.89% for the quarter ended Jun 30, 2026, up 1.84 percentage points from 29.05% a year earlier and up 7.42 percentage points from the prior quarter.
Sanofi (SNY) EBITDA Margin (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Sanofi was 14.82%, down 14.16 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at 27.56%, up 1.17 percentage points from the prior year.
- Annual EBITDA Margin shows a five-year change of -21.79 percentage points (years ended Dec 2020 to Dec 2025).
- In prior years, Sanofi's EBITDA Margin was 26.38% in the year ended Dec 31, 2024 (-3.73 pp), 30.12% in the year ended Dec 31, 2023 (-5.13 pp), 35.24% in the year ended Dec 31, 2022 (+4.85 pp) and 30.39% in the year ended Dec 31, 2021 (-18.95 pp).
- The figure for the quarter ended Jun 30, 2026 stands as the highest quarterly EBITDA Margin since the quarter ended Dec 31, 2024.
- On a year-over-year basis, EBITDA Margin increased in four of the last seven quarters, with an average year-over-year change of -15.17 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was the quarter ended Mar 31, 2025, with a gain of 9.11 percentage points; the weakest was the quarter ended Dec 31, 2024, with a drop of 116.54 percentage points.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 39.10% |
| 10 | Sanofi | 50.28 Bn | 17.06 Bn | 10.79 Bn | 30.89% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.89% |
| Mar 31, 2026 | 23.47% |
| Sep 30, 2025 | 20.68% |
| Jun 30, 2025 | 29.05% |
| Mar 31, 2025 | 26.62% |
| Dec 31, 2024 | 32.93% |
| Sep 30, 2024 | 28.73% |
| Jun 30, 2024 | 25.95% |
| Mar 31, 2024 | 17.51% |
| Dec 31, 2023 | 149.47% |
| Sep 30, 2023 | 21.20% |
| Jun 30, 2023 | 33.39% |
| Mar 31, 2023 | 27.71% |
| Jun 30, 2022 | 28.58% |
| Mar 31, 2022 | 28.51% |
| Jun 30, 2021 | 33.25% |
| Mar 31, 2021 | 27.98% |
| Jun 30, 2020 | 118.29% |
| Mar 31, 2020 | 26.89% |
| Jun 30, 2019 | 36.13% |
Sanofi EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "SNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();